Price is syncing
Reported smart-money activity is still available below.
1 month
-1.7%
price return
Year to date
+7.2%
price return
Recent earnings
3/4
quarters beat
Big funds
8
hold this stock
News tone
Mixed
5 articles, 7 days
Filed positions and reported activity tied to this stock.
8 funds hold a position and insiders have been net selling.
Real smart money
Insiders
Recent coverage and its overall tone.
News
Coverage is mixed
2 bullish · 1 neutral · 2 bearish
Tone of tracked coverage
BeiGene(ONC.US) Officer Sells US$34.59 Million in Common Stock
Leans bearishJul 23BeiGene stock steadies as oncology revenue grows and losses narrow
NeutralJul 20BeiGene(ONC.US) Officer Sells US$62.88 Million in Common Stock
BearishJul 15How Chemotherapy-Free Phase 3 MCL Success At BeOne Medicines (ONC) Has Changed Its Investment Story
BullishJul 14Jefferies Upgrades BeiGene(ONC.US) to Buy Rating, Raises Target Price to $380
BullishJul 13FMR LLC
Q1 2026 13F
$1.1B
position
AlphaYou
